| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Dyne Therapeutics (NASDAQ:DYN) reported its Q4 earnings results on Tuesday, March 5, 2024 at 07:30 AM.
Here's what investors need to know about the announcement.
Dyne Therapeutics missed estimated earnings by -18.0%, reporting an EPS of $-1.09 versus an estimate of $-0.92.
Revenue was down $0 from the same period last year.
Last quarter the company missed on EPS by $0.16 which was followed by a 4.0% drop in the share price the next day.
To track all earnings releases for Dyne Therapeutics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: DYN
